CN116649420A - Nutritional milk powder with effects of nourishing intelligence and promoting digestion and absorption, and its preparation method - Google Patents
Nutritional milk powder with effects of nourishing intelligence and promoting digestion and absorption, and its preparation method Download PDFInfo
- Publication number
- CN116649420A CN116649420A CN202310654516.7A CN202310654516A CN116649420A CN 116649420 A CN116649420 A CN 116649420A CN 202310654516 A CN202310654516 A CN 202310654516A CN 116649420 A CN116649420 A CN 116649420A
- Authority
- CN
- China
- Prior art keywords
- parts
- milk powder
- powder
- nutritional
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000843 powder Substances 0.000 title claims abstract description 147
- 235000013336 milk Nutrition 0.000 title claims abstract description 89
- 239000008267 milk Substances 0.000 title claims abstract description 89
- 210000004080 milk Anatomy 0.000 title claims abstract description 89
- 235000016709 nutrition Nutrition 0.000 title claims abstract description 53
- 238000002360 preparation method Methods 0.000 title claims abstract description 15
- 230000001737 promoting effect Effects 0.000 title claims description 25
- 230000000694 effects Effects 0.000 title description 16
- 238000010521 absorption reaction Methods 0.000 title description 14
- 230000029087 digestion Effects 0.000 title description 8
- 102000007544 Whey Proteins Human genes 0.000 claims abstract description 49
- 108010046377 Whey Proteins Proteins 0.000 claims abstract description 49
- 150000001875 compounds Chemical class 0.000 claims abstract description 47
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 36
- 239000011707 mineral Substances 0.000 claims abstract description 36
- 229940088594 vitamin Drugs 0.000 claims abstract description 34
- 229930003231 vitamin Natural products 0.000 claims abstract description 34
- 235000013343 vitamin Nutrition 0.000 claims abstract description 34
- 239000011782 vitamin Substances 0.000 claims abstract description 34
- 235000021119 whey protein Nutrition 0.000 claims abstract description 33
- 239000006041 probiotic Substances 0.000 claims abstract description 28
- 235000018291 probiotics Nutrition 0.000 claims abstract description 28
- 229920001202 Inulin Polymers 0.000 claims abstract description 24
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims abstract description 24
- 229940029339 inulin Drugs 0.000 claims abstract description 24
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 claims abstract description 23
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 claims abstract description 19
- TZCPCKNHXULUIY-RGULYWFUSA-N 1,2-distearoyl-sn-glycero-3-phosphoserine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OC[C@H](N)C(O)=O)OC(=O)CCCCCCCCCCCCCCCCC TZCPCKNHXULUIY-RGULYWFUSA-N 0.000 claims abstract description 18
- ZWZWYGMENQVNFU-UHFFFAOYSA-N Glycerophosphorylserin Natural products OC(=O)C(N)COP(O)(=O)OCC(O)CO ZWZWYGMENQVNFU-UHFFFAOYSA-N 0.000 claims abstract description 18
- 229960001231 choline Drugs 0.000 claims abstract description 18
- 239000007787 solid Substances 0.000 claims abstract description 18
- 239000006188 syrup Substances 0.000 claims abstract description 17
- 235000020357 syrup Nutrition 0.000 claims abstract description 17
- 239000005862 Whey Substances 0.000 claims abstract description 16
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims abstract description 16
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims abstract description 16
- 235000005822 corn Nutrition 0.000 claims abstract description 16
- 235000020183 skimmed milk Nutrition 0.000 claims abstract description 16
- 108010063045 Lactoferrin Proteins 0.000 claims abstract description 15
- 102000010445 Lactoferrin Human genes 0.000 claims abstract description 15
- 235000021255 galacto-oligosaccharides Nutrition 0.000 claims abstract description 15
- 150000003271 galactooligosaccharides Chemical class 0.000 claims abstract description 15
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 claims abstract description 15
- 235000021242 lactoferrin Nutrition 0.000 claims abstract description 15
- 229940078795 lactoferrin Drugs 0.000 claims abstract description 15
- 235000012680 lutein Nutrition 0.000 claims abstract description 15
- 229960005375 lutein Drugs 0.000 claims abstract description 15
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 claims abstract description 15
- 239000001656 lutein Substances 0.000 claims abstract description 15
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 claims abstract description 15
- 150000003839 salts Chemical class 0.000 claims abstract description 15
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 claims abstract description 15
- 235000008939 whole milk Nutrition 0.000 claims abstract description 15
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 claims abstract description 15
- 239000012528 membrane Substances 0.000 claims abstract description 11
- 230000035764 nutrition Effects 0.000 claims abstract description 10
- 108010071421 milk fat globule Proteins 0.000 claims abstract description 9
- 238000002156 mixing Methods 0.000 claims abstract description 8
- 239000002994 raw material Substances 0.000 claims abstract description 8
- SBJKKFFYIZUCET-JLAZNSOCSA-N Dehydro-L-ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(=O)C1=O SBJKKFFYIZUCET-JLAZNSOCSA-N 0.000 claims abstract 5
- 235000010755 mineral Nutrition 0.000 claims description 32
- 240000008042 Zea mays Species 0.000 claims description 14
- 238000011161 development Methods 0.000 claims description 14
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 14
- 241000186000 Bifidobacterium Species 0.000 claims description 12
- 241000218588 Lactobacillus rhamnosus Species 0.000 claims description 12
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 12
- 230000012010 growth Effects 0.000 claims description 12
- 240000001046 Lactobacillus acidophilus Species 0.000 claims description 11
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 claims description 11
- 229940039695 lactobacillus acidophilus Drugs 0.000 claims description 11
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims description 10
- 239000002131 composite material Substances 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 7
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims description 6
- 229960000304 folic acid Drugs 0.000 claims description 6
- 235000019152 folic acid Nutrition 0.000 claims description 6
- 239000011724 folic acid Substances 0.000 claims description 6
- 238000003756 stirring Methods 0.000 claims description 6
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims description 5
- DKKCQDROTDCQOR-UHFFFAOYSA-L Ferrous lactate Chemical compound [Fe+2].CC(O)C([O-])=O.CC(O)C([O-])=O DKKCQDROTDCQOR-UHFFFAOYSA-L 0.000 claims description 5
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims description 5
- 229930003471 Vitamin B2 Natural products 0.000 claims description 5
- CANRESZKMUPMAE-UHFFFAOYSA-L Zinc lactate Chemical compound [Zn+2].CC(O)C([O-])=O.CC(O)C([O-])=O CANRESZKMUPMAE-UHFFFAOYSA-L 0.000 claims description 5
- 230000009286 beneficial effect Effects 0.000 claims description 5
- 239000004225 ferrous lactate Substances 0.000 claims description 5
- 235000013925 ferrous lactate Nutrition 0.000 claims description 5
- 229940037907 ferrous lactate Drugs 0.000 claims description 5
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 claims description 5
- 239000001095 magnesium carbonate Substances 0.000 claims description 5
- 229910000021 magnesium carbonate Inorganic materials 0.000 claims description 5
- 235000014380 magnesium carbonate Nutrition 0.000 claims description 5
- 229940099596 manganese sulfate Drugs 0.000 claims description 5
- 239000011702 manganese sulphate Substances 0.000 claims description 5
- 235000007079 manganese sulphate Nutrition 0.000 claims description 5
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 claims description 5
- 230000008569 process Effects 0.000 claims description 5
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 claims description 5
- 229960002477 riboflavin Drugs 0.000 claims description 5
- 238000001694 spray drying Methods 0.000 claims description 5
- 235000019164 vitamin B2 Nutrition 0.000 claims description 5
- 239000011716 vitamin B2 Substances 0.000 claims description 5
- 235000019158 vitamin B6 Nutrition 0.000 claims description 5
- 239000011726 vitamin B6 Substances 0.000 claims description 5
- 229940011671 vitamin b6 Drugs 0.000 claims description 5
- 239000011576 zinc lactate Substances 0.000 claims description 5
- 229940050168 zinc lactate Drugs 0.000 claims description 5
- 235000000193 zinc lactate Nutrition 0.000 claims description 5
- 229930003451 Vitamin B1 Natural products 0.000 claims description 4
- 229960001708 magnesium carbonate Drugs 0.000 claims description 4
- 229960003495 thiamine Drugs 0.000 claims description 4
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims description 4
- 235000010374 vitamin B1 Nutrition 0.000 claims description 4
- 239000011691 vitamin B1 Substances 0.000 claims description 4
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 3
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 3
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 3
- 235000019155 vitamin A Nutrition 0.000 claims description 3
- 239000011719 vitamin A Substances 0.000 claims description 3
- 229940045997 vitamin a Drugs 0.000 claims description 3
- 230000000050 nutritive effect Effects 0.000 claims 2
- 239000000203 mixture Substances 0.000 abstract description 5
- 241000209149 Zea Species 0.000 abstract 2
- 230000001954 sterilising effect Effects 0.000 abstract 1
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 description 42
- 230000000052 comparative effect Effects 0.000 description 26
- 241000700159 Rattus Species 0.000 description 25
- 235000020669 docosahexaenoic acid Nutrition 0.000 description 22
- 229940090949 docosahexaenoic acid Drugs 0.000 description 21
- 230000004641 brain development Effects 0.000 description 15
- 230000018109 developmental process Effects 0.000 description 13
- 210000004556 brain Anatomy 0.000 description 12
- 235000018102 proteins Nutrition 0.000 description 9
- 102000004169 proteins and genes Human genes 0.000 description 9
- 108090000623 proteins and genes Proteins 0.000 description 9
- 239000000126 substance Substances 0.000 description 8
- 239000003925 fat Substances 0.000 description 6
- 235000019197 fats Nutrition 0.000 description 6
- 230000000968 intestinal effect Effects 0.000 description 6
- 210000005013 brain tissue Anatomy 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 150000002632 lipids Chemical class 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 206010012735 Diarrhoea Diseases 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- 230000036528 appetite Effects 0.000 description 4
- 235000019789 appetite Nutrition 0.000 description 4
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 4
- 150000002270 gangliosides Chemical class 0.000 description 4
- 230000005056 memory consolidation Effects 0.000 description 4
- 210000005036 nerve Anatomy 0.000 description 4
- 235000015097 nutrients Nutrition 0.000 description 4
- 108090000765 processed proteins & peptides Proteins 0.000 description 4
- 210000000952 spleen Anatomy 0.000 description 4
- 102000014171 Milk Proteins Human genes 0.000 description 3
- 108010011756 Milk Proteins Proteins 0.000 description 3
- 229930003270 Vitamin B Natural products 0.000 description 3
- 210000004958 brain cell Anatomy 0.000 description 3
- -1 compound vitamin Chemical class 0.000 description 3
- 230000001079 digestive effect Effects 0.000 description 3
- 235000020776 essential amino acid Nutrition 0.000 description 3
- 239000003797 essential amino acid Substances 0.000 description 3
- 230000002496 gastric effect Effects 0.000 description 3
- 230000007661 gastrointestinal function Effects 0.000 description 3
- 229960001518 levocarnitine Drugs 0.000 description 3
- 235000021243 milk fat Nutrition 0.000 description 3
- 235000021239 milk protein Nutrition 0.000 description 3
- 239000002858 neurotransmitter agent Substances 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 235000019156 vitamin B Nutrition 0.000 description 3
- 239000011720 vitamin B Substances 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 206010016946 Food allergy Diseases 0.000 description 2
- 235000019742 Vitamins premix Nutrition 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000003044 adaptive effect Effects 0.000 description 2
- 235000021342 arachidonic acid Nutrition 0.000 description 2
- 229940114079 arachidonic acid Drugs 0.000 description 2
- 230000003925 brain function Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 235000013350 formula milk Nutrition 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 230000007087 memory ability Effects 0.000 description 2
- 150000003904 phospholipids Chemical class 0.000 description 2
- 230000002062 proliferating effect Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- DVSZKTAMJJTWFG-SKCDLICFSA-N (2e,4e,6e,8e,10e,12e)-docosa-2,4,6,8,10,12-hexaenoic acid Chemical compound CCCCCCCCC\C=C\C=C\C=C\C=C\C=C\C=C\C(O)=O DVSZKTAMJJTWFG-SKCDLICFSA-N 0.000 description 1
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- GZJLLYHBALOKEX-UHFFFAOYSA-N 6-Ketone, O18-Me-Ussuriedine Natural products CC=CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O GZJLLYHBALOKEX-UHFFFAOYSA-N 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 208000004262 Food Hypersensitivity Diseases 0.000 description 1
- JZNWSCPGTDBMEW-UHFFFAOYSA-N Glycerophosphorylethanolamin Natural products NCCOP(O)(=O)OCC(O)CO JZNWSCPGTDBMEW-UHFFFAOYSA-N 0.000 description 1
- 229930186217 Glycolipid Natural products 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000037208 balanced nutrition Effects 0.000 description 1
- 235000019046 balanced nutrition Nutrition 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 230000005978 brain dysfunction Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- 150000001783 ceramides Chemical class 0.000 description 1
- 210000003710 cerebral cortex Anatomy 0.000 description 1
- 229930183167 cerebroside Natural products 0.000 description 1
- 150000001784 cerebrosides Chemical class 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- WORJEOGGNQDSOE-UHFFFAOYSA-N chloroform;methanol Chemical compound OC.ClC(Cl)Cl WORJEOGGNQDSOE-UHFFFAOYSA-N 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 230000019771 cognition Effects 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 235000018823 dietary intake Nutrition 0.000 description 1
- KAUVQQXNCKESLC-UHFFFAOYSA-N docosahexaenoic acid (DHA) Natural products COC(=O)C(C)NOCC1=CC=CC=C1 KAUVQQXNCKESLC-UHFFFAOYSA-N 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000007071 enzymatic hydrolysis Effects 0.000 description 1
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 description 1
- 230000005281 excited state Effects 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 235000020932 food allergy Nutrition 0.000 description 1
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 description 1
- 229940107187 fructooligosaccharide Drugs 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 230000036449 good health Effects 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000000265 homogenisation Methods 0.000 description 1
- 235000020256 human milk Nutrition 0.000 description 1
- 210000004251 human milk Anatomy 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000008076 immune mechanism Effects 0.000 description 1
- 230000008105 immune reaction Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000007413 intestinal health Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 235000020978 long-chain polyunsaturated fatty acids Nutrition 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000000822 natural killer cell Anatomy 0.000 description 1
- 230000007830 nerve conduction Effects 0.000 description 1
- 230000030363 nerve development Effects 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 210000004498 neuroglial cell Anatomy 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 210000004798 organs belonging to the digestive system Anatomy 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 description 1
- 150000008104 phosphatidylethanolamines Chemical class 0.000 description 1
- 150000003905 phosphatidylinositols Chemical class 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000004224 protection Effects 0.000 description 1
- 210000002027 skeletal muscle Anatomy 0.000 description 1
- 239000008347 soybean phospholipid Substances 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 210000000225 synapse Anatomy 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 230000009044 synergistic interaction Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/16—Agglomerating or granulating milk powder; Making instant milk powder; Products obtained thereby
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
- A23C9/1522—Inorganic additives, e.g. minerals, trace elements; Chlorination or fluoridation of milk; Organic salts or complexes of metals other than natrium or kalium; Calcium enrichment of milk
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
- A23C9/1526—Amino acids; Peptides; Protein hydrolysates; Nucleic acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
- A23C9/1528—Fatty acids; Mono- or diglycerides; Petroleum jelly; Paraffine; Phospholipids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
- A23C9/154—Milk preparations; Milk powder or milk powder preparations containing additives containing thickening substances, eggs or cereal preparations; Milk gels
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
- A23C9/156—Flavoured milk preparations ; Addition of fruits, vegetables, sugars, sugar alcohols or sweeteners
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
- A23C9/158—Milk preparations; Milk powder or milk powder preparations containing additives containing vitamins or antibiotics
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P60/00—Technologies relating to agriculture, livestock or agroalimentary industries
- Y02P60/80—Food processing, e.g. use of renewable energies or variable speed drives in handling, conveying or stacking
- Y02P60/87—Re-use of by-products of food processing for fodder production
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nutrition Science (AREA)
- Inorganic Chemistry (AREA)
- Biophysics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The invention discloses a nutrition milk powder which is nutritional, intelligent, digestible and absorbable and a preparation method thereof, belonging to the technical field of milk powder preparation, and the raw materials comprise: whole milk powder, skimmed milk powder, desalted whey powder, solid corn syrup, inulin, complex probiotics, whey protein powder, galactooligosaccharides, complex vitamins, complex minerals, DHA, AA, lutein, choline, L-carnitine, milk mineral salts, phosphatidylserine and lactoferrin, wherein the whey protein powder is rich in milk fat globule membrane. The preparation method comprises mixing whey protein powder, galactooligosaccharide, solid corn syrup, inulin, lutein, choline, phosphatidylserine, DHA, AA, lactoferrin, compound vitamins, compound minerals and desalted whey powder; and then pouring the whole milk powder, the skimmed milk powder, the milk mineral salt and the L-carnitine into the mixture, uniformly mixing the mixture, sterilizing the mixture, and adding the compound probiotics to obtain the nutritional milk powder.
Description
Technical Field
The invention relates to the technical field of milk powder preparation, in particular to nutrition and intelligence-improving and digestible and absorbable nutrition milk powder and a preparation method thereof.
Background
Children aged 3-15 are in an important period of growth and development, and balanced nutrition intake in the period is beneficial to the growth of the height and weight of the children, and has an important effect on promoting the brain development. The market share of Chinese children milk powder and pregnant woman milk powder is about 60 hundred million yuan according to statistics. Therefore, in recent years, children milk powder with different brands is in a new competitive market in a dispute on the market. The milk powder is different from infant milk powder specified by strict standards, and the milk powder for children 3-15 years old belongs to the prepared milk powder, and the product execution standard is GB 19644-2010 national food safety standard milk powder.
In the existing milk powder classification, a small amount of milk powder is mainly used for infants, and a small amount of milk powder is taken for middle-aged and elderly people, but a small amount of special formula milk powder is used for children milk powder. Chinese patent No. CN102715239a discloses a small peptide high protein children milk powder, which is composed of the following components in percentage by weight: 40-50% of skim milk, 10-14% of desalted whey powder, 6-10% of small peptide substances, 8-12% of carbohydrate, 8-12% of milk protein, 4-7% of vegetable oil, 3-6% of fructo-oligosaccharide, 0.5-1% of mineral premix, 0.5-1% of water-soluble vitamin premix, 0.5-1% of soybean phospholipid, 0.3-0.6% of docosahexaenoic acid (DHA), 0.1-1% of arachidonic acid (ARA), less than 0.1% of taurine and 0.01-0.04% of fat-soluble vitamin premix, wherein the sum of the weight percentages of the components is 100%. It mainly contains small peptide substances which can be directly utilized by children, and has good health care effect on the skin of children. However, the small peptide high protein pediatric milk powder is not suitable for children to absorb. Moreover, food allergy is a food adverse reaction received by an immune mechanism, in which milk protein allergy is common to infants, and is an abnormal or excessively strong immune reaction caused by milk protein. In addition, most of the intelligent milk powder on the market has the effect of promoting the brain development of children by adding the components for promoting the growth and reproduction of neurons, but the absorption effect is not obvious, and the ideal effect of promoting the brain development of children cannot be achieved.
Therefore, how to provide a nutritional milk powder which is beneficial to intelligence and is easy to digest and absorb and suitable for children aged 3-15 is a technical problem which needs to be solved by the technicians in the field.
Disclosure of Invention
In view of the above, the invention provides a nutrition milk powder which is nutritional, intelligent, digestible and absorbable and a preparation method thereof, and the absorption of nutrient elements is promoted, so that the growth and development of children are promoted.
In order to achieve the above purpose, the present invention adopts the following technical scheme:
a nutrition milk powder which is nutritious, intelligent and easy to digest and absorb comprises the following raw materials in parts by weight: 200-300 parts of whole milk powder, 200-300 parts of skim milk powder, 200-300 parts of desalted whey powder, 112-135 parts of solid corn syrup, 22-28 parts of inulin, 32-34 parts of compound probiotics, 20-30 parts of whey protein powder, 10-14 parts of galactooligosaccharides, 2.06-4.7 parts of compound vitamins, 1-3 parts of compound minerals, 2-4 parts of DHA, 1-3 parts of AA, 2-3 parts of lutein, 2-3 parts of choline, 1-2 parts of L-carnitine, 0.2-0.6 part of milk mineral salts, 0.1-0.5 part of phosphatidylserine and 0.1-0.5 part of lactoferrin.
Further, the nutritional milk powder comprises the following raw materials in parts by weight: 225 parts of whole milk powder, 232 parts of skim milk powder, 219 parts of desalted whey powder, 130 parts of solid corn syrup, 23 parts of inulin, 32 parts of compound probiotics, 27 parts of whey protein powder, 13 parts of galacto-oligosaccharides, 3.1 parts of compound vitamins, 1.5 parts of compound minerals, 2 parts of DHA, 3 parts of AA, 2 parts of lutein, 3 parts of choline, 1 part of L-carnitine, 0.3 part of milk mineral salts, 0.4 part of phosphatidylserine and 0.4 part of lactoferrin.
Further, the nutritional milk powder comprises the following raw materials in the optimal weight ratio: 280 parts of whole milk powder, 250 parts of skim milk powder, 250 parts of desalted whey powder, 125 parts of solid corn syrup, 25 parts of inulin, 33 parts of compound probiotics, 25 parts of whey protein powder, 13 parts of galacto-oligosaccharides, 3.9 parts of compound vitamins, 1.2 parts of compound minerals, 3 parts of DHA, 2 parts of AA, 2.5 parts of lutein, 2.6 parts of choline, 1.4 parts of L-carnitine, 0.5 part of milk mineral salt, 0.3 part of phosphatidylserine and 0.3 part of lactoferrin.
Further, the compound probiotics are compounded by bifidobacteria, lactobacillus acidophilus and lactobacillus rhamnosus according to the volume ratio of 1:1:1, wherein the bifidobacteria, the lactobacillus acidophilus and the lactobacillus rhamnosus are all commercial products.
Further, the whey protein powder is rich in milk fat globule membranes.
Further, the multivitamin comprises: the vitamin A is compounded with 100000-200000IU, vitamin C400-600mg, vitamin B1 13000-18000 mug, folic acid 2000-4000 mug, vitamin E1600-4000 IU, vitamin B2 8000-15000 mug and vitamin B6 7000-9000 mug.
Further, the composite mineral comprises ferrous lactate, zinc lactate, magnesium carbonate and manganese sulfate, wherein the mass ratio of the ferrous lactate to the zinc lactate to the magnesium carbonate to the manganese sulfate is 1:2:2:0.01.
As the invention conception same as the technical scheme, the invention also claims a preparation method of the nutrition milk powder which is beneficial to intelligence and is easy to digest and absorb, and the specific process comprises the following steps:
1) Pouring whey protein powder, galactooligosaccharide, solid corn syrup, inulin, lutein, choline, phosphatidylserine, DHA, AA, lactoferrin, compound vitamins, compound minerals and desalted whey powder into a stirrer, and uniformly mixing to obtain a premix 1;
2) Pouring whole milk powder, skimmed milk powder, milk mineral salt and L-carnitine into the premix 1, and uniformly mixing to obtain a premix 2;
3) Pasteurizing the premix 2, controlling the temperature to 95 ℃ for 5 seconds, and then performing spray drying to obtain a dry premix;
4) And adding composite probiotics into the dry premix to obtain the easily digestible and absorbable nutritional milk powder.
Preferably, in step 1), the stirrer is a three-dimensional mixer, the stirring time is 8min, and the stirring rotation speed is 40rpm.
Preferably, in step 3), the specific process of spray drying is: the air inlet temperature is 160 ℃ and the air exhaust temperature is 85 ℃.
As the invention concept same as the technical scheme, the invention also claims the application of the nutritional milk powder prepared by the preparation method in promoting the growth and development of children.
Compared with the prior art, the invention achieves the following technical effects: whey protein powder is easy to digest, has high protein efficacy ratio and high utilization rate, is a fine product in protein, contains all essential amino acids required by human body, the amino acid composition mode of the whey protein powder is almost identical with that of skeletal muscle, the whey protein powder is extremely easy to be absorbed by human body, the protein is one of important components for growth and development of brain cells, the protein accounts for 26% -45% of dry weight of brain, the supplementing protein is particularly important for promoting development of brain, in various proteins, various essential amino acids contained in the whey protein can produce neurotransmitter effect, and is beneficial to intelligence development, and in addition, the whey protein component added in the invention is rich in milk fat globule membrane, the milk fat globule membrane is coated on the surface of milk fat granule, and the milk fat globule membrane comprises the following components: complex milk fats, phospholipids, phosphatidylcholine, phosphatidylethanolamine, phosphatidylinositol, phosphatidylserine, sphingomyelin, glycolipids, gangliosides, ceramides and cerebrosides, proteins and cholesterol. In the brain, about half of the brain tissue is fat or lipid, and the brain tissue is rich in phospholipids and has a high ganglioside concentration. In general, the lipid component structure in milk fat globule membranes is closer to human milk and brain than other sources of lipids, and can be directly supplemented by dietary intake. In composition, milk fat globules membrane is rich in complex lipids, each active lipid has its unique function, and Phosphatidylserine (PS), sphingomyelin (SM) and Gangliosides (GA) are important clinically for brain function. Whey protein powder rich in milk fat globules plays an important role in brain development, cognition, protection and digestive health. The requirements of human bodies are met; DHA and AA are used as long-chain polyunsaturated fatty acid, promote the development of the nervous system of children, and further promote the growth and intelligence development of children, DHA is an important substance for neurotransmitter, brain cells, glial cells and nerve conduction synapse growth and proliferation, is an indispensable nutrient substance in the brain development process, and can promote the development of the thinking ability, memory ability and stress ability of children; the choline can improve and prevent brain dysfunction, promote development of the central nervous system, help brain cell information conduction, and improve memory and information transmission; the whey protein, DHA, AA and choline form the intelligence-improving and brain-developing factors together, and the brain development is promoted by providing essential amino acids for the brain, promoting the nerve development and promoting the generation of neurotransmitters.
The solid corn syrup is mainly maltose syrup which is prepared by taking high-quality corn starch as a raw material and then carrying out enzymatic hydrolysis, and has the functions of increasing sugar content and thickening; inulin has the effects of proliferating bifidobacteria and lactobacillus rhamnosus in human bodies, so that the inulin can inhibit the growth of salmonella and putrefying bacteria in intestines, prevent constipation, regulate gastrointestinal functions, facilitate the synthesis of compound vitamins, promote the absorption of milk powder in compound minerals, obviously improve the activity of antibodies and proliferating cells and NK cells, and enhance the immune function; the L-carnitine can promote the fat to be separated and released, prevent fat from accumulating in a body to control weight, enhance the excretion function of the body, reduce intestinal tract pressure, and inhibit the absorption of sugar by the body by regulating sugar metabolism, so that the sugar is prevented from being converted into fat, and the excessive fat content is prevented from being taken by children to cause kidney burden; therefore, in the invention, the compound probiotics, the L-carnitine, the inulin and the whey protein form the intestinal canal regulating factor together, so that the balance of intestinal canal flora is promoted, the intestinal canal microstructure is improved, and the four substances act together to realize synergistic interaction, promote the absorption of milk powder and further promote the growth and development of children aged 3-15 years.
If the digestion and functional disturbance of children occurs, the burden of digestive organs such as stomach, intestine, liver, spleen and pancreas and the brain to control the digestive absorption of gastrointestinal nerves and appetite centers is increased, and if the nerves in the brain responsible for digestive absorption are always in an excited state, the intelligent activities of central nerves such as language, memory and thinking of cerebral cortex are inhibited. The invention combines the digestion promoting and absorbing substances with the nutrient substances for promoting the brain development, so as to strengthen the gastrointestinal functions of children, and enable organisms to better absorb the nutrient substances for promoting the brain development, thereby achieving the effect of promoting the brain development. In addition, the gastrointestinal burden is relieved, and the nerves in the brain responsible for digestion and absorption can be relieved, so that the inhibition of the development of the central nervous of the brain is avoided, and the effects of improving the brain function of children and promoting the concentration of children are achieved. The invention can promote the brain development of children from the two aspects of preventing the brain development from being inhibited and promoting the absorption of the intelligence-promoting components.
Detailed Description
The following description of the embodiments of the present invention will be made clearly and completely, and it is apparent that the described embodiments are only some embodiments of the present invention, but not all embodiments. All other embodiments, which can be made by those skilled in the art based on the embodiments of the invention without making any inventive effort, are intended to be within the scope of the invention.
The whey protein powder in the examples is rich in milk fat globule membranes.
Example 1
A nutritional intelligence-improving and digestible and absorbable nutritional milk powder, comprising: 200g of whole milk powder, 300g of skim milk powder, 300g of desalted whey powder, 135g of solid corn syrup, 22g of inulin, 32g of compound probiotics, 30g of whey protein powder, 10g of galactooligosaccharide, 2.06g of compound vitamin, 3g of compound mineral, 4g of DHA, 3g of AA, 2g of lutein, 3g of choline, 2g of L-carnitine, 0.2g of milk mineral salt, 0.5g of phosphatidylserine and 0.1g of lactoferrin; the compound probiotics are compounded by bifidobacteria, lactobacillus acidophilus and lactobacillus rhamnosus according to the volume ratio of 1:1:1, wherein the bifidobacteria, the lactobacillus acidophilus and the lactobacillus rhamnosus are all commercial products; the compound vitamins comprise: vitamin A100000IU, vitamin C400mg, vitamin B1 13000 mug, folic acid 2000 mug, vitamin E1600 IU, vitamin B2 8000 mug, vitamin B6 7000 mug; the composite mineral comprises ferrous lactate, zinc lactate, magnesium carbonate and manganese sulfate, and the mass ratio is 1:2:2:0.01.
Example 2
A nutritional intelligence-improving and digestible and absorbable nutritional milk powder, comprising: 225g of whole milk powder, 232g of skim milk powder, 219g of desalted whey powder, 130g of solid corn syrup, 23g of inulin, 32g of compound probiotics, 27g of whey protein powder, 13g of galactooligosaccharide, 3.1g of compound vitamin, 1.5g of compound mineral, 2g of DHA, 3g of AA, 2g of lutein, 3g of choline, 1g of L-carnitine, 0.3g of milk mineral salt, 0.4g of phosphatidylserine and 0.4g of lactoferrin; the compound probiotics are compounded by bifidobacteria, lactobacillus acidophilus and lactobacillus rhamnosus according to the volume ratio of 1:1:1, wherein the bifidobacteria, the lactobacillus acidophilus and the lactobacillus rhamnosus are all commercial products; the compound vitamins comprise: vitamin A158000IU, vitamin C500mg, vitamin B1 15000 μg, folic acid 3500 μg, vitamin E2500 IU, vitamin B2 12000 μg, vitamin B6 8500 μg.
Example 3
A nutritional intelligence-improving and digestible and absorbable nutritional milk powder, comprising: 280g of whole milk powder, 250g of skim milk powder, 250g of desalted whey powder, 125g of solid corn syrup, 25g of inulin, 33g of complex probiotics, 25g of whey protein powder, 13g of galacto-oligosaccharides, 3.9g of complex vitamins, 1.2g of complex minerals, 3g of DHA, 2g of AA, 2.5g of lutein, 2.6g of choline, 1.4g of L-carnitine, 0.5g of milk mineral salts, 0.3g of phosphatidylserine and 0.3g of lactoferrin; the compound probiotics are compounded by bifidobacteria, lactobacillus acidophilus and lactobacillus rhamnosus according to the volume ratio of 1:1:1, wherein the bifidobacteria, the lactobacillus acidophilus and the lactobacillus rhamnosus are all commercial products; the compound vitamins comprise: 180000IU of vitamin A, 350mg of vitamin C, 1 16000 mug of vitamin B, 3200 mug of folic acid, 3500IU of vitamin E, 212500 mug of vitamin B and 7500 mug of vitamin B.
Example 4
A nutritional intelligence-improving and digestible and absorbable nutritional milk powder, comprising: 300g of whole milk powder, 200g of skim milk powder, 200g of desalted whey powder, 112g of solid corn syrup, 28g of inulin, 34g of compound probiotics, 20g of whey protein powder, 14g of galactooligosaccharide, 4.7g of compound vitamin, 1g of compound mineral, 2g of DHA, 1g of AA, 3g of lutein, 2g of choline, 3g of L-carnitine, 0.6g of milk mineral salt, 0.1g of phosphatidylserine and 0.5g of lactoferrin; the compound probiotics are compounded by bifidobacteria, lactobacillus acidophilus and lactobacillus rhamnosus according to the volume ratio of 1:1:1, wherein the bifidobacteria, the lactobacillus acidophilus and the lactobacillus rhamnosus are all commercial products; the compound vitamins comprise: vitamin A200000IU, vitamin C600mg, vitamin B118000 mug, folic acid 4000 mug, vitamin E4000 IU, vitamin B2 15000 mug and vitamin B6 9000 mug; the composite mineral comprises ferrous lactate, zinc lactate, magnesium carbonate and manganese sulfate, and the mass ratio is 1:2:2:0.01.
The preparation method of the nutritional milk powder in examples 1-4 comprises the following steps:
1) Pouring whey protein powder, galactooligosaccharide, solid corn syrup, inulin, lutein, choline, phosphatidylserine, DHA, AA, lactoferrin, compound vitamins, compound minerals and desalted whey powder into a stirrer, and uniformly mixing to obtain a premix 1; the stirrer is a three-dimensional mixer, the stirring time is 8min, and the stirring rotating speed is 40rpm;
2) Pouring whole milk powder, skimmed milk powder, milk mineral salt and L-carnitine into the premix 1, and uniformly mixing to obtain a premix 2;
3) Pasteurizing the premix 2, controlling the temperature to 95 ℃ for 5 seconds, and then performing spray drying to obtain a dry premix; the specific process of fog drying is as follows: the air inlet temperature is 160 ℃, and the air exhaust temperature is 85 ℃;
4) And adding composite probiotics into the dry premix to obtain the easily digestible and absorbable nutritional milk powder.
Example 5
The total protein content, acid soluble protein content and solid content of the milk powder prepared in examples 1 to 4 were measured and shown in Table 1;
TABLE 1
| Example 1 | Example 2 | Example 3 | Example 4 | |
| Total protein content% | 30.24 | 32.73 | 31.19 | 32.81 |
| Acid soluble protein content | 7.53 | 6.49 | 7.64 | 6.75 |
| Solids content% | 96.37 | 97.46 | 95.27 | 97.72 |
Example 6
Selecting 100 volunteers with weak spleen and stomach, frequent diarrhea and poor intestinal stress to participate in an evaluation test of the nutritional milk powder prepared in the embodiment 3, wherein 35 of 3-5 years old, 27 of 6-9 years old and 38 of 10-15 years old are taken for 150g of the nutritional milk powder prepared in the embodiment 3 every morning and evening, wherein 33 of the 3-5 years old volunteers show no diarrhea symptom after taking the milk powder for one month, and the appetite is increased, 22 of the 6-9 years old volunteers show no diarrhea symptom after taking the milk powder for one month, and the appetite is increased, the attention is concentrated during learning, and the spleen and stomach functions are enhanced in all the volunteers, the appetite is increased, and the weight of 19 volunteers is 2-3 cm higher during eating, and the specific results are shown in Table 2;
TABLE 2
As shown in Table 2, the nutritional milk powder prepared by the invention can effectively regulate intestinal health and improve intestinal stress function for children aged 3-15, and the total effective rate is up to 93%.
Comparative examples 1-3 were also set, specifically as follows:
comparative example 1: the difference from example 3 is that inulin is removed, the other components and the quality are unchanged;
comparative example 2: the difference from example 3 is that the removal of the L-carnitine, the other components and the quality are unchanged;
comparative example 3: the difference from example 3 is that the complex probiotics are removed, and the other components and the quality are unchanged;
the nutritional milk powder of the above comparative examples 1 to 3 was prepared according to the preparation method of example 3, and simultaneously, 50 volunteers with weak spleen and stomach, frequent diarrhea, and poor intestinal stress were selected for the comparative example 1 to 3, respectively, to participate in the evaluation test of the nutritional milk powder of the present invention prepared in comparative examples 1 to 3,
the grouping situation is as follows:
comparative example 1: 20 years old 3-5 years old, 13 years old 6-9 years old, and 17 years old 10-15 years old;
comparative example 2: 14 years old 3-5 years old, 18 years old 6-9 years old, 18 years old 10-15 years old;
comparative example 3: 18 years old 3-5 years old, 17 years old 6-9 years old 17 years old 10-15 years old
150g of the nutritional milk powder prepared in example 3 was taken daily in the morning and evening, and the specific results are shown in Table 3;
TABLE 3 Table 3
Comparing tables 2 and 3, it can be seen that after removing any one of inulin, compound probiotics or L-carnitine, the intestinal tract regulating function of the nutritional milk powder is deteriorated, the absorption effect is deteriorated, the promoting effect on the growth of children is greatly reduced, the total effective rate is between 42 and 56 percent, and compared with the nutritional milk powder provided by the invention, the total effective rate is greatly reduced.
Example 7
The brain DHA content experiment is carried out by taking rats as experimental objects, and the influence of the nutrition intelligence-improving and digestible and absorbable nutrition milk powder provided by the invention on the brain development of the rats is detected.
60 rats of 100+ -10 g were selected and after one week of adaptive feeding, they were randomly divided into six groups of 10 animals each. Six groups of rats were normal feed group, example 1 group, example 2 group, example 3 group, comparative example 1 group, comparative example 2 group, respectively. Examples 1-3 groups were fed with the milk powder of examples 1-3, and group 1 was fed with the same milk powder of example 3, characterized in that no inulin, complex probiotics and l-carnitine component were contained, and group 2 was fed with the same milk powder of example 3, characterized in that no whey protein, DHA, AA, choline, inulin, complex probiotics and l-carnitine component were contained. The six groups of rats are continuously fed with 25g of the milk powder daily for 4 weeks, the weight is weighed once every three days, the rats are fasted for 12 hours after the last gastric lavage, the rats are anesthetized and the abdominal arteries are sacrificed after whole blood collection, brain tissues are separated, the total fat in the rats is extracted by chloroform-methanol solution (2:1, V/V) after homogenization, and the relative content of DHA in the total fatty acid is measured by a gas chromatography, and the results are shown in Table 4:
TABLE 4 Table 4
| Conventional feed group | Example 1 group | Example 2 group | Example 3 group | Comparative example 1 group | Comparative example 2 group | |
| DHA(％) | 9.53 | 12.80 | 12.55 | 13.25 | 11.24 | 9.74 |
The results in Table 4 show that compared with the control group, after rats eat the milk powder prepared by the invention, the DHA content in brain tissue fatty acid is obviously improved, which indicates that the DHA content in brain tissue of rats can be improved by eating the milk powder of the invention; the comparative example 1, in which the digestion promoting component was removed, showed that the DHA content in the brain was significantly inferior to that of the group of examples 1 to 3, indicating that the development of gastrointestinal function could promote the absorption of the intelligence promoting component by the organism, the comparative example 2, in which the intelligence promoting and digestion promoting component was removed, showed that the DHA content in the brain of rats was not much different from that of the conventional feed group. In conclusion, the digestion promoting component and the intelligence promoting component can play a synergistic role to effectively promote the brain development of rats.
Example 8
Comparative example 4 was set up as follows:
comparative example 4: the difference from example 3 is that inulin, complex probiotics and the l-carnitine component are absent.
Comparative example 5: the difference from example 3 is that whey protein powder is a normal whey protein powder without milk fat globule membrane.
Comparative example 6: the difference from example 3 is that whey protein, DHA, AA, choline, inulin, complex probiotics and L-carnitine components are absent.
Nutritional milk powder in the above comparative examples 4 to 6 was prepared according to the preparation method of example 3.
70 rats of 100+ -10 g were selected and after one week of adaptive feeding, they were randomly divided into seven groups of 10 animals each. Seven groups of rats were normal feed group, example 1 group, example 2 group, example 3 group, comparative example 4 group, comparative example 5 group, comparative example 6 group, respectively. Examples 1-3 groups were fed with the milk powder of examples 1-3 and comparative examples 4-6 groups were fed with the milk powder of comparative examples 4-6. The six groups of rats were continuously fed with 25g of the above milk powder daily for 4 weeks, and after the last feeding, bench jump tests were performed, respectively.
Jump test: the rats were placed in a reaction box for 3min, and then stimulated with 36V ac power. The rats were then placed on an insulated platform and the latency of each rat to jump off the platform for the first time, the number of mistakes per rat to jump off the platform in 5min and the number of animals to jump off the platform for each group (memory acquisition) were recorded. The test was repeated 24 hours later, and the latency of the first jump-down platform, the number of errors of the jump-down platform within 3 minutes and the number of animals (memory consolidation) of each group of jump-down platforms were recorded, and the experimental results are shown in table 5.
TABLE 5
As can be seen from table 5, taking the milk powder of the present invention can significantly improve the memory acquisition and memory consolidation ability of rats, it can be inferred that the milk powder of the present invention can promote the brain development of rats, thereby improving the comprehension and memory ability of rats; after the absorption promoting components are removed, the memory acquisition and memory consolidation capacity of the rats are improved compared with those of the conventional feed group, but the effects are not obvious and are not as good as those of the groups 1-3; after replacing whey protein powder rich in milk plasma globule membrane with conventional whey protein powder, rat brain development was inferior to that of examples 1-3 of the present invention; after removing the intelligence-improving and absorption-promoting components, the memory acquisition and memory consolidation capability of the rats are comparable to those of the conventional feed group.
In the present specification, each embodiment is described in a progressive manner, and each embodiment is mainly described in a different point from other embodiments, and identical and similar parts between the embodiments are all enough to refer to each other.
The previous description of the disclosed embodiments is provided to enable any person skilled in the art to make or use the present invention. Various modifications to these embodiments will be readily apparent to those skilled in the art, and the generic principles defined herein may be applied to other embodiments without departing from the spirit or scope of the invention. Thus, the present invention is not intended to be limited to the embodiments shown herein but is to be accorded the widest scope consistent with the principles and novel features disclosed herein.
Claims (10)
1. The nutritional milk powder is characterized by comprising the following raw materials in parts by weight: 200-300 parts of whole milk powder, 200-300 parts of skim milk powder, 200-300 parts of desalted whey powder, 112-135 parts of solid corn syrup, 22-28 parts of inulin, 32-34 parts of compound probiotics, 20-30 parts of whey protein powder, 10-14 parts of galactooligosaccharides, 2.06-4.7 parts of compound vitamins, 1-3 parts of compound minerals, 2-4 parts of DHA, 1-3 parts of AA, 2-3 parts of lutein, 2-3 parts of choline, 1-2 parts of L-carnitine, 0.2-0.6 part of milk mineral salts, 0.1-0.5 part of phosphatidylserine and 0.1-0.5 part of lactoferrin.
2. The nutritional intelligence-improving and digestible and absorbable nutritional milk powder according to claim 1 is characterized by comprising the following raw materials in parts by weight: 225 parts of whole milk powder, 232 parts of skim milk powder, 219 parts of desalted whey powder, 130 parts of solid corn syrup, 23 parts of inulin, 32 parts of compound probiotics, 27 parts of whey protein powder, 13 parts of galacto-oligosaccharides, 3.1 parts of compound vitamins, 1.5 parts of compound minerals, 2 parts of DHA, 3 parts of AA, 2 parts of lutein, 3 parts of choline, 1 part of L-carnitine, 0.3 part of milk mineral salts, 0.4 part of phosphatidylserine and 0.4 part of lactoferrin.
3. The nutritional intelligence-improving and digestible and absorbable nutritional milk powder according to claim 1, which is characterized by comprising the following raw materials in optimal weight part ratio: 280 parts of whole milk powder, 250 parts of skim milk powder, 250 parts of desalted whey powder, 125 parts of solid corn syrup, 25 parts of inulin, 33 parts of compound probiotics, 25 parts of whey protein powder, 13 parts of galacto-oligosaccharides, 3.9 parts of compound vitamins, 1.2 parts of compound minerals, 3 parts of DHA, 2 parts of AA, 2.5 parts of lutein, 2.6 parts of choline, 1.4 parts of L-carnitine, 0.5 part of milk mineral salt, 0.3 part of phosphatidylserine and 0.3 part of lactoferrin.
4. A nutritional and intellectual and digestible and absorbable nutritional milk powder according to any one of claims 1-3, wherein the compound probiotics are compounded by bifidobacteria, lactobacillus acidophilus and lactobacillus rhamnosus according to the volume ratio of 1:1:1, and the whey protein powder is rich in milk fat globule membranes.
5. The nutritional intelligence-improving and digestible absorbable nutritive milk powder according to claim 4, wherein the multivitamin comprises: the vitamin A is compounded with 100000-200000IU, vitamin C400-600mg, vitamin B1 13000-18000 mug, folic acid 2000-4000 mug, vitamin E1600-4000 IU, vitamin B2 8000-15000 mug and vitamin B6 7000-9000 mug.
6. The nutritional and intelligence-improving digestible absorbable nutritive milk powder according to claim 5, wherein the composite mineral comprises ferrous lactate, zinc lactate, magnesium carbonate and manganese sulfate in a mass ratio of 1:2:2:0.01.
7. A preparation method of nutrition and intelligence-improving and digestible and absorbable nutrition milk powder is characterized by comprising the following steps:
1) Pouring whey protein powder, galactooligosaccharide, solid corn syrup, inulin, lutein, choline, phosphatidylserine, DHA, AA, lactoferrin, compound vitamins, compound minerals and desalted whey powder into a stirrer, and uniformly mixing to obtain a premix 1;
2) Pouring whole milk powder, skimmed milk powder, milk mineral salt and L-carnitine into the premix 1, and uniformly mixing to obtain a premix 2;
3) Pasteurizing the premix 2, controlling the temperature to 95 ℃ for 5 seconds, and then performing spray drying to obtain a dry premix;
4) And adding composite probiotics into the dry premix to obtain the easily digestible and absorbable nutritional milk powder.
8. The method for preparing the nutritional milk powder which is beneficial to intelligence and is easy to digest and absorb according to claim 7, wherein in the step 1), the stirrer is a three-dimensional mixer, the stirring time is 8min, and the stirring rotating speed is 40rpm.
9. The method for preparing the nutritional milk powder which is nutritional, intelligent and digestible and absorbable according to claim 7, wherein in the step 3), the specific process of spray drying is as follows: the air inlet temperature is 160 ℃ and the air exhaust temperature is 85 ℃.
10. The use of the nutritional milk powder prepared by the preparation method of claim 9 for promoting the growth and development of children.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202310654516.7A CN116649420B (en) | 2023-06-05 | 2023-06-05 | Nutritional milk powder with effects of nourishing intelligence and promoting digestion and absorption, and its preparation method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202310654516.7A CN116649420B (en) | 2023-06-05 | 2023-06-05 | Nutritional milk powder with effects of nourishing intelligence and promoting digestion and absorption, and its preparation method |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN116649420A true CN116649420A (en) | 2023-08-29 |
| CN116649420B CN116649420B (en) | 2024-05-24 |
Family
ID=87727517
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202310654516.7A Active CN116649420B (en) | 2023-06-05 | 2023-06-05 | Nutritional milk powder with effects of nourishing intelligence and promoting digestion and absorption, and its preparation method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN116649420B (en) |
Citations (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101902918A (en) * | 2007-10-19 | 2010-12-01 | 方塔拉合作集团有限公司 | Keep or increase the method for growth or cognitive development |
| CN103637219A (en) * | 2013-12-27 | 2014-03-19 | 浙江贝因美科工贸股份有限公司 | Probiotics composition as well as application and infant food thereof |
| CN105532883A (en) * | 2015-12-21 | 2016-05-04 | 海普诺凯营养品有限公司 | Formula goat milk powder for infants and young children and preparation method thereof |
| US20170020180A1 (en) * | 2014-04-09 | 2017-01-26 | Nestec S.A. | Gender specific synthetic nutritional compositions and nutritional systems comprising them |
| CN107568341A (en) * | 2017-10-28 | 2018-01-12 | 卜球 | A kind of formula milk and its production method for being advantageous to human body intestinal canal health |
| CN110692741A (en) * | 2019-11-12 | 2020-01-17 | 湖南贝恩叮当猫婴童用品有限公司 | Formula milk powder for promoting bone growth and preparation method thereof |
| CN112155057A (en) * | 2020-08-25 | 2021-01-01 | 石家庄君乐宝乳业有限公司 | High-protein thickened modified milk powder and preparation method thereof |
| CN113678898A (en) * | 2020-05-19 | 2021-11-23 | 培臻生物科技(上海)有限公司 | Milk powder beneficial to development and growth of children and preparation method thereof |
| US20230165264A1 (en) * | 2020-07-28 | 2023-06-01 | Beijing Sanyuan Foods Co., Ltd. | Maternal milk powder containing probiotics and prebiotics and preparation method thereof |
| US20230263179A1 (en) * | 2020-09-09 | 2023-08-24 | Beijing Sanyuan Foods Co., Ltd. | Infant formula milk powder rich in milk fat globule membrane protein, phospholipids and oligosaccharides and preparation method therefor |
-
2023
- 2023-06-05 CN CN202310654516.7A patent/CN116649420B/en active Active
Patent Citations (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101902918A (en) * | 2007-10-19 | 2010-12-01 | 方塔拉合作集团有限公司 | Keep or increase the method for growth or cognitive development |
| CN103637219A (en) * | 2013-12-27 | 2014-03-19 | 浙江贝因美科工贸股份有限公司 | Probiotics composition as well as application and infant food thereof |
| US20170020180A1 (en) * | 2014-04-09 | 2017-01-26 | Nestec S.A. | Gender specific synthetic nutritional compositions and nutritional systems comprising them |
| CN106455658A (en) * | 2014-04-09 | 2017-02-22 | 雀巢产品技术援助有限公司 | Gender specific synthetic nutritional compositions and nutritional systems comprising them |
| CN105532883A (en) * | 2015-12-21 | 2016-05-04 | 海普诺凯营养品有限公司 | Formula goat milk powder for infants and young children and preparation method thereof |
| CN107568341A (en) * | 2017-10-28 | 2018-01-12 | 卜球 | A kind of formula milk and its production method for being advantageous to human body intestinal canal health |
| CN110692741A (en) * | 2019-11-12 | 2020-01-17 | 湖南贝恩叮当猫婴童用品有限公司 | Formula milk powder for promoting bone growth and preparation method thereof |
| CN113678898A (en) * | 2020-05-19 | 2021-11-23 | 培臻生物科技(上海)有限公司 | Milk powder beneficial to development and growth of children and preparation method thereof |
| US20230165264A1 (en) * | 2020-07-28 | 2023-06-01 | Beijing Sanyuan Foods Co., Ltd. | Maternal milk powder containing probiotics and prebiotics and preparation method thereof |
| CN112155057A (en) * | 2020-08-25 | 2021-01-01 | 石家庄君乐宝乳业有限公司 | High-protein thickened modified milk powder and preparation method thereof |
| US20230263179A1 (en) * | 2020-09-09 | 2023-08-24 | Beijing Sanyuan Foods Co., Ltd. | Infant formula milk powder rich in milk fat globule membrane protein, phospholipids and oligosaccharides and preparation method therefor |
Non-Patent Citations (5)
| Title |
|---|
| ANA NIETO-RUIZ ET AL: "Cortical Visual Evoked Potentials and Growth in Infants Fed with Bioactive Compounds-Enriched Infant Formula: Results from COGNIS Randomized Clinical Trial", 《NUTRIENTS》, pages 237 - 238 * |
| 中国食品科学技术学会: "乳脂肪球膜及其配料的科学共识", 《中国食品学报》, 30 April 2022 (2022-04-30), pages 471 - 476 * |
| 温欣怡等: "2 种不同乳脂球膜对小鼠智力、抗疲劳及抗氧化功能的作用", 《乳业科学与技术》, 1 January 2023 (2023-01-01), pages 1 - 8 * |
| 温欣怡等: "2 种不同乳脂球膜对小鼠智力、抗疲劳及抗氧化功能的作用", 《乳业科学与技术》, pages 1 - 8 * |
| 邹东旭;芦明春;郑晓丽;邵文培;: "不同分子质量的菊粉对乳酸杆菌生长的影响", 《大连工业大学学报》, no. 01, pages 19 - 21 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN116649420B (en) | 2024-05-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US9943097B2 (en) | Nutritional composition | |
| CN111227045B (en) | Application of dairy product in promoting growth of length of mammal | |
| JP2011516054A (en) | Long-chain polyunsaturated fatty acids (LC-PUFA) in maternal nutrition during pregnancy and lactation | |
| US6511685B1 (en) | Dietary supplement derived from fermented milks for the prevention of osteoporosis | |
| CN111345358A (en) | Child formula goat milk powder rich in lactophospholipid and preparation method thereof | |
| CN110074397A (en) | A kind of upgrowth and development of children tailored version clinical nutrition formula and preparation method thereof | |
| CN111657497A (en) | Ketogenic diet for resisting food protein allergy and preparation method thereof | |
| CN112998080A (en) | Infant formula milk powder added with yolk phospholipid, soybean phospholipid and milk phospholipid | |
| CN1065411C (en) | Healthful nutrition milk powder and production method | |
| EP1803358A1 (en) | Infant immunological formula | |
| CN108013452A (en) | A kind of puerperal abdominal flatulence gas tailored version clinical nutrition formula and preparation method thereof | |
| CN105076417A (en) | Intestine protective formula milk powder and preparation method thereof | |
| CN109965271A (en) | A kind of children's brain growth tailored version clinical nutrition formula and preparation method thereof | |
| CN116649420B (en) | Nutritional milk powder with effects of nourishing intelligence and promoting digestion and absorption, and its preparation method | |
| EP3285602A1 (en) | Compositions comprising choline and derivatives thereof, uses thereof and processes for their preparation | |
| CN114190441A (en) | Formula milk powder for promoting growth and development of children and preparation method thereof | |
| CN111387486A (en) | Special medical formula nutrition powder for liver disease patients and preparation method thereof | |
| CN115500391A (en) | Fatty acid ester composition containing LPLn/OPLn | |
| CN116548608B (en) | Full-nutrition formula powder for children and preparation method and application thereof | |
| CN114145346A (en) | Food composition, application of food composition in improving or promoting magnesium absorption and infant formula milk powder | |
| CN113729211A (en) | Composition and preparation method and application thereof | |
| CN113973923A (en) | Goat milk-based total nutrient formula powder for special medical purposes and preparation method thereof | |
| CN109845826A (en) | A kind of infant milk powder for simulating breast milk fatty acids structure and composition | |
| CN109845827A (en) | A kind of infant milk powder for simulating breast-feeding infant intestinal microecology | |
| CN115804410B (en) | Infant formula containing prebiotic composition for promoting growth of bifidobacterium longum subspecies YLGB-1496 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |